A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C

Slides:



Advertisements
Similar presentations
Development of guideline-based quality indicators for recurrent miscarriage E. van den Boogaard, M. Goddijn, N.J. Leschot, F. van der Veen, J.A.M. Kremer,
Advertisements

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
E.H. Duran, D. Dowling-Lacey, S. Bocca, L. Stadtmauer, S. Oehninger 
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
Norbert Gleicher, Andrea Weghofer, David H. Barad 
S.M. Nelson, A. La Marca  Reproductive BioMedicine Online 
External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients  Scott M.
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response  William L. Ledger, Bart C.J.M. Fauser, Paul.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis  Annelies Overbeek, Frank J. Broekmans, Wouter.
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Increased exposure to dioxin-like compounds is associated with endometriosis in a case–control study in women  Peter Simsa, Attila Mihalyi, Greet Schoeters,
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation  Jacob Farhi, Avi Ben.
Publication productivity in IVF in Europe, 1990–2006
Factors affecting embryo viability and uterine receptivity: insights from an analysis of the UK registry data  Stephen A. Roberts, Mark Hann, Daniel R.
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation  Giovanna Sighinolfi,
Gillian M. Lockwood  Reproductive BioMedicine Online 
Female gender pre-selection by maternal diet in combination with timing of sexual intercourse – a prospective study  A.M. Noorlander, J.P.M. Geraedts,
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
Utility of age-specific serum anti-Müllerian hormone concentrations
What’s on the mind of IVF consumers?
S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells 
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Fertility preservation consultation for women with cancer: are we helping patients make high-quality decisions?  Jayeon Kim, Allison M. Deal, Ursula Balthazar,
Zehong Zhou, Rong Li, Jie Qiao  Reproductive BioMedicine Online 
Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing  Norbert Gleicher, Andrea Weghofer, David H.
Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve  Bulent Urman, Ebru Alper, Kayhan Yakin, Ozgur.
Yaniv Zipori, Jigal Haas, Howard Berger, Eran Barzilay 
Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.
Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone  Anne-Sophie Hamy, Raphaël Porcher, Caroline Cuvier, Sylvie Giacchetti, Marie-Hélène.
Male age negatively influences clinical pregnancy rate in women younger than 40 years undergoing donor insemination cycles  Su-Ann Koh, Katherine Sanders,
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer  Anne Perdrix, Mathilde Saint-Ghislain,
Effect of chromosomal polymorphisms of different genders on fertilization rate of fresh IVF–ICSI embryo transfer cycles  Ji Liang, Yongsheng Zhang, Yang.
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Anna Pia Ferraretti, Paul Devroey, M. Cristina Magli, Luca Gianaroli 
Pietro Gambadauro, Ramesan Navaratnarajah 
Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance  Shimon Segal,
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Testosterone concentrations in early pregnancy: relation to method of conception in an infertile population  Ruth B. Lathi, Sharon E. Moayeri, Charitha.
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Is parental consanguinity associated with reduced ovarian reserve?
Progesterone elevation on the day of HCG administration may affect rescue ICSI  Bo Huang, Zhou Li, Lixia Zhu, Dan Hu, Qun Liu, Guijin Zhu, Hanwang Zhang 
Norbert Gleicher, Andrea Weghofer, David H. Barad 
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years?  Kirsten Tryde Macklon, Erik Ernst, Anders Nyboe Andersen,
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
Implantation of fresh and thawed–warmed embryos in single embryo transfer cycles: interpreting the initial beta-HCG  Cynthia K. Sites, Peter St Marie,
A. G. Sutcliffe, J. T. Manning, A. Katalanic, A. Ludwig, M. Mehta, J
Reproductive BioMedicine Online
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
Yakoub Khalaf, Susan Bewley, Peter Braude 
Serum anti-müllerian hormone levels in women with secondary amenorrhea
Frequency of low serum LH is associated with increased early pregnancy loss in IVF/ICSI cycles  Chin-Der Chen, Yi-Ting Chiang, Po-Kai Yang, Mei-Jou Chen,
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles  A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C. Sala, C. Masciullo, A. Volpe, D. Toniolo  Reproductive BioMedicine Online  Volume 21, Issue 4, Pages 463-469 (October 2010) DOI: 10.1016/j.rbmo.2010.05.009 Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Distribution of serum anti-Müllerian hormone (AMH) concentrations in the study population. Data showed a non-normal distribution. Vertical lines=an ideal bell-shaped normal distribution curve. Reproductive BioMedicine Online 2010 21, 463-469DOI: (10.1016/j.rbmo.2010.05.009) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Correlation between log anti-Müllerian hormone (logAMH) concentration and age of women. Regression analysis revealed that age-related changes were best fitted by a polynomial function, logAMH=1.0547+(0.0546 age)−(0.0015 age2). Median and 95% confidence interval are shown. R2=0.24; P<0.001. Reproductive BioMedicine Online 2010 21, 463-469DOI: (10.1016/j.rbmo.2010.05.009) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 Serum anti-Müllerian hormone (AMH) concentrations in the whole population (n=277). Bars indicate the 2.5th, 25th, 50th, 75th and 97.5th percentiles. Reproductive BioMedicine Online 2010 21, 463-469DOI: (10.1016/j.rbmo.2010.05.009) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 4 Serum anti-Müllerian hormone (AMH) concentrations throughout the reproductive period. Median, lower (2.5th percentile) and upper (97.5th percentile) limits and 25th and 75th percentiles are shown. Reproductive BioMedicine Online 2010 21, 463-469DOI: (10.1016/j.rbmo.2010.05.009) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions